Pricing Log in Create free account

Cognition Therapeutics, Inc. (CGTX) vs Cingulate Inc. (CING)

Cognition Therapeutics, Inc. and Cingulate Inc. are both Biotechnology companies. Cognition Therapeutics, Inc. and Cingulate Inc. are of similar size ($61.7M and $60.4M). Across the 8 metrics below, Cognition Therapeutics, Inc. leads on 7 and Cingulate Inc. on 1.

Valuation

Metric CGTX CING Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 1.76 2.39 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (26.56%) (86.56%) (34.89%)
Free cash flow yield (30.51%) (37.36%) (24.52%)

Profitability

Metric CGTX CING Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (83.76%) (198.74%) (50.12%)
Return on assets (57.33%) (123.76%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CGTX CING Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 62.79% 59.12% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGTX CING Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.03 3.50 4.89
Net debt to EBITDA 0.78 0.51 1.01

Dividend

Metric CGTX CING Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CGTX CING Biotechnology median
Market cap 60.42m 61.66m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack